Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,354Revenue (TTM) $M2,018Net Margin (%)5.3Altman Z-Score3.9
Enterprise Value $M4,105EPS (TTM) $3.7Operating Margin %7.8Piotroski F-Score7
P/E(ttm)41.1Beneish M-Score-2.3Pre-tax Margin (%)6.9Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %4.5Quick Ratio3.1Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %-7.7Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow113y-y EBITDA Growth Rate %-6.4ROA % (ttm)3.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)5.8Gross Margin Increase y-yY

Gurus Latest Trades with BIO.B

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BIO.B is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIO.B: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.3826.18view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$12023.43view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.3924.06view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.8527.85view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.4129.46view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.6232.69view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.9332.32view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.2231.98view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.631.54view

Press Releases about BIO.B :

Quarterly/Annual Reports about BIO.B:

    News about BIO.B:

    Articles On GuruFocus.com
    WL Ross Holding Becomes Chemical Company, First Pacific Advisers Takes 20% Stake May 25 2016 
    A Few Stocks to Weed Out of Your Portfolio May 25 2016 
    Asking the Right Questions May 25 2016 
    2 CEOs Make Big Buys of Their Companies’ Stocks May 25 2016 
    Unlike SunEdison, Canadian Solar Can Manage Its Debt May 25 2016 
    Netflix: What the Numbers Say Versus What Investors Think May 25 2016 
    Alan Fournier Acquires Stake in PayPal Holdings May 25 2016 
    GernsteinFisher - Globalization: Past, Present, and Future May 25 2016 
    Third Avenue Management Q2 2016 International Value Letter May 25 2016 
    Third Avenue Management Comments on Weyerhaeuser May 25 2016 

    More From Other Websites
    Bio-Rad Unveils Amplichek II Quality Control, the First in a Series of Controls for the Molecular... May 23 2016
    Bio-Rad Laboratories, Inc. :BIO.B-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
    Bio-Rad posts 1Q profit May 05 2016
    Bio-Rad posts 1Q profit May 05 2016
    Bio-Rad posts 1Q profit May 05 2016
    Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent May 05 2016
    Bio-Rad to Report First-Quarter 2016 Financial Results Thursday, May 5, 2016 Apr 13 2016
    Bio-Rad Laboratories, Inc. Earnings Analysis: 2015 By the Numbers Feb 29 2016
    Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro... Feb 25 2016
    Bio-Rad Reports Fourth-Quarter and Full-Year 2015 Financial Results Feb 25 2016
    CORRECTION - Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday,... Feb 16 2016
    Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer Feb 08 2016
    Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016 Feb 02 2016
    Bio-Rad Joins Food Safety Consortium With IBM and Mars, Incorporated Jan 12 2016
    Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics Jan 11 2016
    Bio-Rad Named One of the 2015 Top 100 Bay Area Innovators by Thomson Reuters Jan 05 2016
    Bio-Rad Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : December 25,... Dec 25 2015
    Bio-Rad's TANGO infinity Receives FDA 510(k) Clearance for U.S. Markets Dec 21 2015
    FDA Okays Bio-Rad D-100 for HbA1c (Diabetes) Testing Dec 21 2015
    Bio-Rad Laboratories, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)